North American Construction Group Ltd. Announces Share Purchase Program In Canada And The United States

ACHESON, Alberta, April 06, 2021 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA/NYSE:NOA) today announced that it intends to commence a normal course issuer bid (the “NCIB”) to purchase, for cancellation, up to 2,000,000 common shares in the capital of the Company (“Common Shares”), which represents approximately 9.7% of the public float (as defined in the TSX Company Manual) and approximately 6.7% of the issued and outstanding Common Shares as of April 6, 2021. As at April 5, 2021, the Company had 29,949,528 Common Shares issued and outstanding. In connection with the shares purchasable under the NCIB, the Company has entered into an automatic share purchase plan (“ASPP”) with its designated broker.

Purchases of Common Shares under the NCIB may be made through the facilities of the Toronto Stock Exchange (“TSX”), the New York Stock Exchange (“NYSE”) and alternative trading systems by means of open market transactions or by such other means as may be permitted by the TSX and under applicable securities laws. Under the NCIB, and in order to comply with applicable securities laws, the Company will purchase a maximum of 1,497,476 Common Shares (or approximately 5% of the issued and outstanding voting common shares) on the NYSE and alternative trading systems.

The Company believes that the current market price of its Common Shares does not fully reflect their underlying value and that current market conditions provide opportunities for the Company to acquire Common Shares at attractive prices. In the Company’s view, a repurchase of Common Shares would be an effective use of its cash resources and would be in the best interests of the Company and its shareholders. It would both enhance liquidity for shareholders seeking to sell and provide an increase in the proportionate interests of shareholders wishing to maintain their positions.

The NCIB is expected to commence on or about April 9, 2021 and will terminate no later than April 8, 2022, provided that purchases may not be made on the NYSE until April 12, 2021. All purchases of Common Shares will be made in compliance with applicable TSX and NYSE rules. The average daily trading volume of the Common Shares on the TSX for the six calendar months preceding March 31, 2021 is 97,185 Common Shares. In accordance with the TSX rules and subject to the exemption for block purchases, a maximum daily repurchase of 25% of this average may be made, representing 24,296 Common Shares. The price per Common Share will be based on the market price of such shares at the time of purchase in accordance with regulatory requirements.

Pursuant to the ASPP, the designated broker may purchase up to 2,000,000 Shares until the expiry of the NCIB on April 8, 2022. Such purchases will be determined by the broker at its sole discretion, based on the purchasing parameters set out by the Company in accordance with the rules of the TSX, applicable securities laws and the terms of the ASPP. Purchases of Common Shares under the ASPP may be made through the facilities of the TSX, the NYSE and alternative trading systems. The ASPP has been pre-cleared by the TSX and will be effective as of April 9, 2021. The ASPP will terminate on the earliest of the date on which: (i) the NCIB expires; (ii) the maximum number of Common Shares have been purchased under the NCIB; and (iii) the Company terminates the ASPP in accordance with its terms. Concurrent with the establishment of the ASPP, the Company has confirmed to the broker that it was then not aware of any material undisclosed or non-public information with respect to the Company or any securities of the Company. During the term of the ASPP, the Company will not communicate any material undisclosed or non-public information to the trading staff of the broker; accordingly, the broker may make purchases regardless of whether a trading blackout period is in effect or whether there is material undisclosed or non-public information about the Company at the time that purchases are made under the ASPP. In the event that the ASPP is materially varied, suspended or terminated, the Company will issue a news release advising of such variation, suspension or termination, as applicable.

The Company repurchased a total of 2,300,000 Common Shares under the NCIB it previously announced on March 9, 2020. Of those, 1,705,655 Common Shares were purchased within the previous 12 months at a weighted average purchase price of $11.85 CDN per Common Share.

About the Company

North American Construction Group Ltd. (www.nacg.ca) is one of Canada’s largest providers of heavy civil construction and mining contractors. For more than 65 years, NACG has provided services to large oil, natural gas and resource companies.

For further information contact:
Jason Veenstra, CPA, CA
Chief Financial Officer
North American Construction Group Ltd.
(780) 948-2009
[email protected]
www.nacg.ca

Forward-Looking Information

The information provided in this news release contains forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words “will”, “intends” “expect”, “may”, “could”, “believe”, “anticipate”, “should” or similar expressions. In particular, this news release contains forward-looking statements and information relating to the Company’s belief that the NCIB is in the best interests of the Company and its shareholders and that underlying value of the Company may not be reflected in the market price of the Common Shares, the Company’s intentions regarding the NCIB and whether the Company will receive the requisite approval of the TSX in respect of the NCIB. Forward-looking statements in this news release are being made by NACG based on certain assumptions that NACG has made in respect thereof as at the date of this news release. These forward-looking statements are not guarantees of future performance and are subject to a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from anticipated future results, performance or achievement expressed or implied by such forward-looking statements and information. The material factors or assumptions used to develop such forward-looking statements include, and the risks and uncertainties to which such forward-looking statements are subject, are highlighted in the MD&A for the quarter and year ended December 31, 2020. Actual results could differ materially from those contemplated by such forward-looking statements because of any number of factors and uncertainties, many of which are beyond NACG’s control. Undue reliance should not be placed upon forward-looking statements and NACG undertakes no obligation, other than those required by applicable law, to update or revise those statements. For more complete information about NACG, please read our disclosure documents filed with the SEC and the CSA. These free documents can be obtained by visiting EDGAR on the SEC website at www.sec.gov or on the CSA website at www.sedar.com.



Miles Kilburn to Retire as Chairman of Everi’s Board of Directors

CEO Michael Rumbolz to Become Chairman

Ronald Congemi Named Lead Independent Director

LAS VEGAS, April 06, 2021 (GLOBE NEWSWIRE) — Everi Holdings Inc. (NYSE: EVRI) (“Everi” or the “Company”), a premier provider of land-based and digital casino gaming content and machines, financial technology, and player loyalty solutions, today announced that E. Miles Kilburn, Chairman of the Board of Directors of Everi, has informed the Company he will retire from the Board of Directors (the “Board”) and will not stand for reelection at the Company’s 2021 Annual Meeting of Stockholders, which will be held on May 19, 2021, Mr. Kilburn’s last day of service on the Board. The Board has appointed Everi Chief Executive Officer, Michael D. Rumbolz, to become Chairman upon Mr. Kilburn’s retirement. The Board also named Ronald V. Congemi, a member of the Board for the last eight years, as Lead Independent Director, effective immediately.

The Board intends to review the opportunity to fill the open director position created by Mr. Kilburn’s retirement through the addition of a new director that would continue to advance the gender, cultural and professional diversity of its current composition and that would bring additional gaming, financial technology, digital and leadership experience to the Board. In addition, the Board’s deep commitment to excellence in corporate governance is reflected in its regular review of and ongoing work to further its existing senior leadership succession planning to ensure long-term continuity. The Board has already identified preferred candidates to ensure this continuity of leadership. While it presently anticipates continuing to pursue its succession plan, additional qualified candidates will continue to be considered.

E. Miles Kilburn Retires

E. Miles Kilburn has served as a member of the Board since March 2005 and has been Chairman since 2008. During his time on the Board, the Company has grown, evolved, and established itself as a leading provider of casino gaming content and products, financial technology solutions and player loyalty services to the gaming industry through both organic growth and 11 acquisitions. Mr. Kilburn’s vast experience and success in the payments industry helped guide Everi’s path to become a leading provider of such solutions to the gaming industry and in leveraging its capabilities to build a comprehensive portfolio of financial technology products and services. In 2014, the Company completed the acquisition of Multimedia Games, Inc., which at the time was a niche supplier of primarily Class II casino gaming equipment and is now one of the fastest-growing providers of slot entertainment for the gaming industry with a multi-year track record of revenue growth and increased operating results.

“Having served with distinction on the Board for 15 years including as Chairman since 2008, Miles has led our Board’s efforts to develop and adapt corporate governance practices that promote long-term value creation, transparency to stakeholders and accountability to our stockholders,” said Ronald V. Congemi, Lead Independent Director for Everi. “Since the Company’s IPO in 2005, Miles’ wisdom, experience and guidance has helped Everi develop and evolve into one of the most exciting growth companies in the gaming industry. On behalf of the Board and the entire organization I want to thank Miles for his long-time service to the Company and wish him continued success in the future.”

Miles Kilburn said, “I have enjoyed my long association with Everi, and take great satisfaction in the Company’s evolution into a leading supplier of gaming and financial service solutions to the gaming industry. Everi has strong business momentum and its financial recovery from the impact of the COVID-19 pandemic is well underway with significant opportunities for growth ahead of it. With Mike as Chairman and an exceptional leadership team in place who continue to develop and execute on Everi’s growth initiatives, the Company will continue to benefit from a strong foundation. With my business interests expanding and taking more of my time, and continuity of the Company’s stewardship in place, it’s a fitting time to retire and provide an opportunity for someone to bring new insights to the Board.”

Michael D. Rumbolz to Become Chairman

Upon Mr. Kilburn’s retirement, Michael D. Rumbolz will jointly serve as Chairman of the Board and Chief Executive Officer. Mr. Rumbolz has served as Everi’s Chief Executive Officer since April 1, 2020, having previously served as President and Chief Executive Officer from May 2016 through March 2020, and Interim President and Chief Executive Officer from February 2016 to May 2016, and has been a member of the Board since 2010. From 2008 to 2010, he served as a consultant to the Company advising upon various strategic, product development and customer relations matters. Prior to that, he served as the Chairman and Chief Executive Officer of Cash Systems, Inc., a provider of cash access services to the gaming industry, from 2005 until 2008 when the Company acquired Cash Systems, Inc.

Mr. Rumbolz has provided consulting services and held various public and private sector employment positions in the gaming industry, including serving as a Member and Chairman of the Nevada Gaming Control Board from 1985 to 1988. He previously served as the Vice Chairman of the Board of Casino Data Systems, the President and CEO of Anchor Gaming, the Director of Development for Circus Circus Enterprises (acquired by Mandalay Bay Group), and the President of Casino Windsor at the time of its construction and opening in Windsor, Ontario. In addition, Mike was the Chief Deputy Attorney General of the State of Nevada.

Mike currently serves as a Director of Seminole Hard Rock Entertainment, LLC and as a Director of VICI Properties Inc. (NYSE: VICI).

“Since first joining the Everi Board in 2010, I’ve had a deep and ongoing commitment to the success of Everi,” said Mr. Rumbolz. “Over the last several years, we’ve established a deep bench of experienced and talented leadership and an employee workforce that is second-to-none in my opinion. I am most proud of how we have focused on building a company culture that strives to be more diverse and collaborative, which is yielding more new and enhanced products than-ever-before and has laid a strong foundation for continued growth. I believe Everi is in the early innings of our growth trajectory, and I look forward to being a part of that continuing journey. I, along with the rest of the Board and Company, wish all the best to Miles in his next and future endeavors.”

Ronald V. Congemi as Lead Independent Director

Ronald V. Congemi has served as a member of the Board since February 2013. He is an active member of the Philadelphia Federal Reserve’s Payments Advisor Council and has served as a member of the board of Clearent LLC, a merchant processing company and as a consultant to the Acxsys Corporation of Canada, the operating arm of the Interac debit network of Canada. He also served four years as Chief Executive Officer of First Data’s Debit Services Group, with responsibility for all debit and Star branded network services. Prior, he was Senior Vice President of Concord EFS, Inc. and President of Concord’s Network Services Group, with management responsibility for the Star network and financial institution processing.

Mr. Congemi founded Star Systems, Inc. and built it into the country’s largest ATM and PIN-secure debit network during his 17-year tenure as President and CEO. Previously, he held positions of increasing responsibility at Visa International and began his career with Texas Commerce Bank in the information systems and bank card management divisions.

He has held positions as Chairman of the Electronic Funds Transfer Association, Chairman of Star Systems, Inc., Chairman of TNS Canada and Chairman of Early Warning Systems, LLC.

About Everi

Everi’s mission is to be the industry leader by reimagining the gaming experience. Focused on player engagement and assisting our casino customers to operate more efficiently, the Company develops entertaining game content and gaming machines, gaming systems, and services for land-based and iGaming operators. The Company is also the preeminent provider of trusted financial technology solutions that power the casino floor while improving operational efficiencies and fulfilling regulatory compliance requirements, including products and services that facilitate convenient and secure cash and cashless financial transactions, self-service player loyalty tools and applications, and regulatory and intelligence software. For more information, please visit www.everi.com, which is updated regularly with financial and other information about the Company.

Join Everi on Social Media

Twitter: https://twitter.com/everi_inc
LinkedIn: https://www.linkedin.com/company/everi
Facebook: https://www.facebook.com/EveriHoldingsInc/
Instagram: https://www.instagram.com/everi_inc

Everi Holdings Inc. – Media Relations:

Dona Cassese
VP of Marketing
[email protected]

Everi Holdings Inc. – Investor Relations:

William Pfund
SVP, Investor Relations
702-676-9513 or [email protected]

JCIR

Richard Land, James Leahy
212-835-8500 or [email protected]



Rise Run Capital acquires LYN Fishing

DALLAS, April 06, 2021 (GLOBE NEWSWIRE) — Rise Run Capital LLC (“Rise Run”) is pleased to announce that its portfolio company House of Outdoors Inc. (“HOO”), acquired LYN Fishing (“LYN”) on March 31, 2021. LYN creates high quality fishing line for a variety of angling styles, methods and environments.

“As HOO’s portfolio continues to grow, we are committed to investing in businesses and providing a platform to continue to nurture and grow young, innovative brands to ensure our customers have the best experience on the water,” said Corbin Cook, Rise Run Co-Founding Partner. “By acquiring LYN, HOO is well positioned to gain additional traction in the fishing line, lure and bait categories. We’re confident that LYN’s strategy and its founder Sam Moore, align in a way that will undoubtedly benefit our customer and we’re confident our industry-leading management team at HOO will take LYN to the next level.”

Legal counsel was provided by Spencer Fane LLP led by Brian Memory, Chris Summers and Macy Matthews. The transaction closed with debt financing provided by CrossFirst Bank.

 

About Rise Run Capital

Rise Run Capital is a Dallas-based private equity firm which invests flexible and creative capital into middle market companies with EBITDA between $2 and $15 million, strong management teams, attractive and defensible market positions and minimal customer and supplier concentrations. Rise Run focuses on consumer/outdoor products, healthcare, and service companies. Rise Run partners pride themselves on being collaborative team members alongside founders and current management teams. 

This communication is for informational purposes and is not intended to be, nor should it be construed or used as an offer to sell, or a solicitation of any offer to buy shares or limited partnership interests in any investments managed by Rise Run Capital.

Attachment



Corbin Cook
Rise Run Capital LLC
214-883-6010
[email protected]

Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference

RANCHO CUCAMONGA, Calif., April 06, 2021 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and HR, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P. Corporate Administration Center and Sales & Marketing, will participate in an Analyst-Moderated fireside chat at the Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 3:45 pm Eastern time.

This presentation will be made available webcast and may be accessed by visiting Amphastar’s Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 90 days following the presentation.

About Amphastar:

Amphastar is a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin active pharmaceutical ingredient products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. More information is available at the Company’s website at www.amphastar.com.

The Amphastar Pharmaceuticals’ logo and other trademarks or service marks of Amphastar Pharmaceuticals, Inc., including, but not limited to Primatene®, Amphadase® and Cortrosyn®, are the property of Amphastar Pharmaceuticals, Inc.

Forward Looking Statements

All statements in this press release that are not historical are forward-looking statements. These statements are not historical facts but rather are based on Amphastar’s historical performance and its current expectations, estimates, and projections regarding Amphastar’s business, operations, and other similar or related factors. Words such as “may,” “might,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Amphastar’s control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Amphastar’s filings with the Securities and Exchange Commission, including in the Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 15, 2021. You can locate these reports through the Company’s website at http://ir.amphastar.com and on the SEC’s website at www.sec.gov. The forward-looking statements in this release speak only as of the date of the release. Amphastar undertakes no obligation to revise or update information or any forward-looking statements in this press release to reflect events or circumstances in the future, even if new information becomes available or if subsequent events cause Amphastar’s expectations to change.

Contact:
 
Bill Peters
Chief Financial Officer
(909) 476-3416
 



Avista Corp. First Quarter 2021 Earnings Conference Call and Webcast Announced

SPOKANE, Wash., April 06, 2021 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) will hold its quarterly conference call and webcast to discuss first quarter 2021 results on Wednesday, May 5, 2021, at 10:30 a.m. Eastern Daylight Time. A news release with first quarter 2021 earnings information will be issued at 7:05 a.m. Eastern Daylight Time on May 5, 2021.

This call can be accessed on Avista’s website at investor.avistacorp.com, or you can listen to the call by dialing (855) 806-8606, Confirmation number 6982215.

A replay of the call will be available through May 10, 2021. Call (855) 859-2056, Confirmation number 6982215 # to listen to the replay. The webcast will be archived for one year on the Avista Corp. Web site at investor.avistacorp.com.

Avista Corp. is an energy company involved in the production, transmission and distribution of energy as well as other energy-related businesses. Avista Utilities is the operating division that provides electric service to 400,000 customers and natural gas to 367,000 customers. Its service territory covers 30,000 square miles in eastern Washington, northern Idaho and parts of southern and eastern Oregon, with a population of 1.7 million. Alaska Energy and Resources Company is an Avista subsidiary that provides retail electric service to 17,000 customers in the city and borough of Juneau, Alaska, through its subsidiary Alaska Electric Light and Power Company. Avista stock is traded under the ticker symbol “AVA.”  For more information about Avista, please visit www.avistacorp.com.

Avista Corp. and the Avista Corp. logo are trademarks of Avista Corporation.

To unsubscribe from Avista’s news release distribution, send reply message to [email protected]

Contact:      
Media:     Avista 24/7 Media Access (509) 495-4174
      Laurine Jue (509) 495-2510, [email protected]
Investors:     John Wilcox (509) 495-4171, [email protected]



The Chefs’ Warehouse Supports Restaurants With New Campaign

The Chefs’ Warehouse kicks off a new Welcome Back campaign that supports the restaurant industry with digital marketing through the reopening period.

RIDGEFIELD, Conn., April 06, 2021 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ:CHEF), a premier distributor of specialty food products in North America, highlights its chef customers during this reopening period with a new Welcome Back campaign. The campaign will utilize digital channels to support customers by shooting photos of their restaurants, chefs, and signature dishes using the Chefs’ Warehouse incredible assortment of ingredients. The Company will begin launching the campaign this week.

“We are very excited to continue to support our customers as they recover from such a challenging year,” said Christopher Pappas, Chairman and Chief Executive Officer of The Chefs’ Warehouse, Inc. “We service most major cities in the United States and are eager to see the vibrancy of culinary culture return. We have been honored to partner with the restaurant community to help those in need during this crisis and will continue to do our part.”

The Chefs’ Warehouse has made it a priority to support local and national charitable organizations that work to alleviate the strain COVID-19 has placed on communities. In 2020, since the pandemic began, the Chefs’ Warehouse has donated over 8 million dollars in food and supplies to fight hunger and support the restaurant community.

The Chefs’ Warehouse is a family-operated business that has maintained a close relationship with its restaurant customers, suppliers, and the overall culinary community since its inception over 35 years ago.

About The Chefs’ Warehouse

The Chefs’ Warehouse, Inc. (http://www.chefswarehouse.com) is a premier distributor of specialty food products in the United States and Canada focused on serving the specific needs of chefs who own and/or operate some of the nation’s leading menu-driven independent restaurants, fine dining establishments, country clubs, hotels, caterers, culinary schools, bakeries, patisseries, chocolatiers, cruise lines, casinos and specialty food stores. The Chefs’ Warehouse, Inc. carries and distributes more than 55,000 products to more than 34,000 customer locations throughout the United States and Canada.

Contact:
Investor Relations
Jim Leddy, CFO, (718) 684-8415



Oncocyte to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference

IRVINE, Calif., April 06, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that management is scheduled to participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference.

Presentation details:

Date: April 14, 2021
Time: 10:15am EDT

The presentation will be accessible via a live webcast at https://wsw.com/webcast/needham107/ocx/2075172

Following the conference, a webcast replay of the presentation will be available on the Investor section of the company’s website, www.oncocyte.com.

About Oncocyte Corporation

Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the cancer care continuum. The Company, through its proprietary tests and pharmaceutical services business, aims to help save lives and improve outcomes by accelerating and optimizing the diagnosis and treatment of cancer. The Company’s tests and services present multiple opportunities to advance cancer care while also driving revenue growth for the Company. Oncocyte recently launched DetermaRx™, a test that identifies early-stage lung cancer patients who are at high risk for cancer recurrence post-resection and predicts benefit from adjuvant chemotherapy. Oncocyte has also launched DetermaIO™, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies, as a research use only tool for pharmaceutical and academic clinical trials. To complement DetermaIO™, the Company anticipates launching DetermaTx™, a test to assess mutational status of a tumor to help identify the appropriate targeted therapy, in the second half of 2021. The Company previously announced its planned acquisition of Chronix Biomedical Inc. and its TheraSure™ CNI Monitor test, and also plans to continue with the development of DetermaMx™ as the Company seeks to expand into the blood-based monitoring market. Oncocyte’s pharmaceutical services provide pharmaceutical companies who are developing new cancer treatments a full suite of molecular testing services to support the drug development process.

DetermaRx, DetermaIO, DetermaMx, and DetermaTx are trademarks of Oncocyte Corporation. Therasure is a trademark of Chronix Biomedical Inc.

Investor Contact

Bob Yedid
LifeSci Advisors, LLC
646-597-6989
[email protected]

 



NuVasive’s Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement

Simplify® Cervical Artificial Disc achieved the highest overall clinical success rate at both one- and two-levels compared to any other approved cervical disc

PR Newswire

SAN DIEGO, April 6, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify® Cervical Artificial Disc (Simplify Disc) received approval from the U.S. Food and Drug Administration (FDA) for two-level cervical total disc replacement (cTDR).

“This approval is an incredible achievement for the Simplify Disc and further broadens the growth opportunities for the NuVasive C360 portfolio,” said Massimo Calafiore, executive vice president, Global Business Units at NuVasive. “There is immense surgeon excitement for this latest edition to our cervical offering, and the expanded two-level indication provides greater opportunities to bring the most clinically effective technology in the cTDR market to more patients.”

The Simplify Disc demonstrated clinical superiority at 24 months compared to anterior cervical discectomy and fusion (ACDF) in a two-level FDA Investigational Device Exemption (IDE) study.1 In this study, the device proved an overall success rate that was nearly 10% higher when compared to ACDF.1 Additionally, a greater percentage of patients achieved success in a 15-point Neck Disability Index (NDI) and had no neurological deterioration components in relation to fusion.1 Overall, the Simplify Disc demonstrates clinical superiority to ACDF1 and has the highest overall clinical success rate compared to any other approved cervical disc at both one- and two-levels.2 It is one of three devices approved for use in two-level cTDR procedures.

“The field of spinal arthroplasty continues to evolve and the Simplify Disc’s two-level FDA approval represents another significant milestone in improving the standard of patient care in spine,” said Domagoj Coric, M.D., chief of neurosurgery at Atrium Health Carolinas Medical Center in Charlotte, North Carolina. “The Simplify Disc’s clinical superiority to ACDF, coupled with its unique design properties, makes it an important tool in how spine surgeons treat cervical radiculopathy.”

The Simplify Disc is part of the NuVasive C360™ portfolio, which offers comprehensive, procedurally integrated solutions for the cervical spine across ACDF, posterior cervical fusion, and cTDR procedures. The device is designed with key performance functions, including:

  • Radiologic Design: The disc, uniquely comprised of PEEK on ceramic materials, allows for enhanced visualization through MRI postoperatively compared to alternative devices, a key imaging modality in spine;
  • Anatomic Disc Heights: The Simplify Disc is anatomically designed and includes 4mm, 5mm, and 6mm options. The 4mm disc, the lowest disc height in the market,2 closely matches the native disc height of a wide range of patients; and
  • Physiologic Motion: The proprietary disc design provides unique articulation which allows for a variable center of rotation for each treated level and is designed to closely mimic the motion dynamics of a natural spine segment. The Simplify Disc has the highest NDI success rate compared to any other approved two-level cervical disc.2

NuVasive will feature the Simplify Disc at the upcoming International Society for the Advancement of Spine Surgery (ISASS) 21st Annual Conference in Miami, Fla. This includes a discussion of the device in a technology session focused on the cervical spine on Thursday, May 13, 2021. In addition, the results of the Simplify Disc’s one-level, 24-month, multi-center FDA IDE trial will be shared in a podium presentation on Friday, May 14, 2021.


About NuVasive

NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company’s less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company’s comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,700 employees and operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com.


Forward-Looking Statements

NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products, the Company’s ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

1 Simplify Cervical Artificial Disc – P200022
2 Data on file. Based on review of publicly available materials at the time of this release.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasives-simplify-disc-receives-fda-approval-for-two-level-cervical-total-disc-replacement-301263404.html

SOURCE NuVasive, Inc.

SemiLEDs to Announce Fiscal Second Quarter 2021 Financial Results on Thursday, April 8, 2021

SemiLEDs to Announce Fiscal Second Quarter 2021 Financial Results on Thursday, April 8, 2021

HSINCHU, Taiwan–(BUSINESS WIRE)–
SemiLEDs Corporation (NASDAQ:LEDS), will report financial results for the 2021 fiscal Second quarter ended February 28, 2021 after market close on Thursday, April 08, 2021.

About SemiLEDs

SemiLEDs develops, manufactures, and sells LED chips and LED components for general lighting applications, including street lights and commercial, industrial, system and residential lighting, along with specialty industrial applications such as ultraviolet (UV) curing, medical/cosmetic, counterfeit detection, horticulture, architectural lighting and entertainment lighting. SemiLEDs sells blue, white, green and UV LED chips.

Christopher Lee

Chief Financial Officer

+886-37-586788

[email protected]

KEYWORDS: Taiwan Asia Pacific

INDUSTRY KEYWORDS: Consumer Electronics Technology Photography Manufacturing Other Manufacturing Hardware

MEDIA:

Logo
Logo

Inogen Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

Inogen Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 20th Annual Needham Virtual Healthcare Conference.

Inogen’s President and CEO, Nabil Shabshab, and CFO, Alison Bauerlein, are scheduled to present on Monday, April 12th, 2021 at 10:15 a.m. ET. Interested parties can access the webcast from the News / Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

Investor Relations Contact:

Matthew Pigeon

[email protected]

Media Contact:

Byron Myers

805-562-0503

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Medical Devices Health

MEDIA: